Canadian commercial dermatology company Q3 revenue up 10%, beats expectations

Jones Lang LaSalle Incorporated

05/11/2025 12:38

Corrects company name in headline

Overview

JLL Q3 revenue grows 10% yr/yr, beating analyst expectations

Adjusted EPS for Q3 beats consensus, rising 29% yr/yr

Company repurchased $70 mln in shares this quarter, up 118% yr/yr

Outlook

JLL raises mid-point of full-year Adjusted EBITDA target

Company expects continued momentum into the fourth quarter

JLL sees alignment of data, tech, and AI as growth drivers

Result Drivers

TRANSACTIONAL REVENUE - Growth driven by Capital Markets Services, with strong performance in investment sales, debt advisory, and equity advisory

RESILIENT REVENUE - Growth in Project Management and Workplace Management within Real Estate Management Services

TECHNOLOGY AND AI - Strategic focus on data, technology, and AI capabilities supports long-term growth

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$6.51 bln
$6.48 bln (7 Analysts)
Q3 Adjusted EPS
Beat
$4.50
$4.23 (9 Analysts)
Q3 EPS
$4.61
Q3 Adjusted Net Income
Beat
$217.40 mln
$207.56 mln (6 Analysts)
Q3 Adjusted EBITDA
Beat
$347.30 mln
$345.96 mln (9 Analysts)
Q3 Free Cash Flow
$567.60 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

Wall Street's median 12-month price target for Jones Lang LaSalle Inc is $359.00, about 16.7% above its November 4 closing price of $299.04

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nPn5mqXKJa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)